Beam Therapeutics Inc. (BEAM) Retained Earnings (Accumulated Deficit) USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Beam Therapeutics Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2019 to 2024.
  • Beam Therapeutics Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$1.29 B, a 11.7% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$1.29 B -$135 M -11.7% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$1.19 B -$133 M -12.5% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 -$1.33 B -$314 M -30.8% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$1.24 B -$327 M -36% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$1.15 B -$316 M -37.8% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 -$1.06 B -$289 M -37.6% Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$1.02 B -$315 M -44.8% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 -$909 M -$234 M -34.6% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 -$837 M -$238 M -39.8% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 -$768 M -$371 M -93.2% Dec 31, 2021 10-K 2023-02-28
Q3 2021 -$704 M -$401 M -133% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 -$675 M -$408 M -152% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 -$599 M -$366 M -157% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 -$398 M -$195 M -95.8% Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$302 M Sep 30, 2020 10-Q 2020-11-10
Q2 2020 -$268 M Jun 30, 2020 10-Q 2020-08-12
Q1 2020 -$234 M Mar 31, 2020 10-Q 2020-05-12
Q4 2019 -$203 M Dec 31, 2019 10-K 2021-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.